Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noé Group is a London-based family office and independent investment group that manages a diverse portfolio across real estate, private equity, and venture capital. The firm is particularly active in the healthcare and life sciences sectors, where it focuses on the acquisition and development of specialized real estate assets such as research and development campuses, laboratory spaces, and medical facilities. Through its investment arms, including Capreon and Goldacre, the group also provides growth capital to innovative companies in medical technology, digital infrastructure, and AI-driven drug discovery. Noé Group's strategy emphasizes long-term value creation and the support of critical infrastructure that enables scientific innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noé Group.